The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
Open accessAbstract
Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR EC KO mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-κB. In this study we pre-treated these GR EC KO mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR EC KO mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-α and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR EC KO mice show increased iNOS production and NF-κB activation despite treatment with dexamethasone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, the presence of endothelial GR is required for dexamethasone to rescue the animals from lipopolysaccharide (LPS)-induced morbidity and mortality [24].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
The Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery Disease
Fernández-Hernando, C., Ackah, E., Yu, J., Suárez, Y., Murata, T., Iwakiri, Y., Prendergast, J., Miao, R. Q., Birnbaum, M. J., & Sessa, W. C. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.007 · Cited by 284
Self-citationExpression and Subcellular Distribution of the β-Isoform of the Human Glucocorticoid Receptor*
Oakley, R. H., Webster, J. C., Sar, M., Parker, C. R., & Cidlowski, J. A. (1997) · Endocrinology · doi:10.1210/endo.138.11.5501 · Cited by 193
Genetic dissection of glucocorticoid receptor function in mice
Tronche, F., Kellendonk, C., Reichardt, H. M., & Schütz, G. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80007-5 · Cited by 180
Evolution of glucocorticoid receptors with different glucocorticoid sensitivity
Stolte, E. H., van Kemenade, B. M. L. V., Savelkoul, H. F. J., & Flik, G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06703 · Cited by 162
Cited by
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4914-x · Cited by 220
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
Srivastava, S. P., Zhou, H., Setia, O., Liu, B., Kanasaki, K., Koya, D., Dardik, A., Fernandez-Hernando, C. F., & Goodwin, J. E. (2021) · Nature Communications · doi:10.1038/s41467-021-22617-y · Cited by 138
Self-citationThe Glucocorticoid Receptor in Cardiovascular Health and Disease
Liu, B., Zhang, T., Knight, J. K., & Goodwin, J. E. (2019) · Cells · doi:10.3390/cells8101227 · Cited by 144
Self-citationAnnane, D., Pastores, S. M., Arlt, W., BALK, R. A., Beishuizen, A., Briegel, J., Carcillo, J. A., Christ‐Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002724 · Cited by 123
Endothelial Response to Glucocorticoids in Inflammatory Diseases
Zielińska, K. A., Moortel, L. V., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00592 · Cited by 131
Metadata
- Authors
- Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C.
- Affiliations
- Yale University (US)
- Corresponding author
- Goodwin, Julie E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-09
- Volume
- 9
- Issue
- 10
- Pages
- e108126
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4191990
- OpenAlex
- W1987467309
- Cited by
- 19
- References
- 30
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 6 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 1
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Yale University (P30 DK079310)
- National Institutes of Health (PO1 HL107205, HL107205, HL61371, HL64793, HL081190)
- National Heart, Lung, and Blood Institute (HL-081190, HL-61371, R01HL096670, HL-64793, R01HL064793, R01HL081190, HL096670, R01HL061371, P01HL107205, R37HL061371)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK59635, U24DK059635, K08DK078623, P30DK079310)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- dexamethasone, lipopolysaccharide, sepsis, NF-κB activation, inducible nitric oxide synthase, nitric oxide, TNF-α, interleukin-6, anti-inflammatory therapy
- MeSH terms
- Animals, Anti-Inflammatory Agents, Dexamethasone, Endothelium, Glucocorticoids, Lipopolysaccharides, Male, Nitric Oxide, Receptors, Glucocorticoid, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Sepsis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS. https://app.cochat.ai/papers/10.1371/journal.pone.0108126
- The paper
- Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C. (2014). Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS. PLoS ONE. https://doi.org/10.1371/journal.pone.0108126
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.